NCT05311111 (TunDRA) is a NA clinical trial of distal radial artery approach in Vascular Access Complication, sponsored by General Administration of Military Health, Tunisia.

Who is sponsoring NCT05311111?

NCT05311111 is sponsored by General Administration of Military Health, Tunisia.

What drugs are being tested in NCT05311111?

Interventions in NCT05311111: distal radial artery approach, conventional radial artery approach.

What condition does NCT05311111 study?

NCT05311111 studies Vascular Access Complication, Coronary Artery Disease.

Is NCT05311111 still recruiting?

NCT05311111 is currently status unknown. Last updated 11 April 2022.

Last reviewed 2022-04-11 · How we verify

NCT05311111: TunDRA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy and Safety of the Distal Radial Approach

Status unknown NA Last updated 11 April 2022

What this trial tests

NA trial testing distal radial artery approach in Vascular Access Complication in 250 participants. Status unknown.

Timeline

1 February 2022

Primary endpoint
30 May 2022

30 June 2022

Quick facts

Lead sponsor	General Administration of Military Health, Tunisia
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	250
Start date	1 February 2022
Primary completion	30 May 2022
Estimated completion	30 June 2022
Sites	1 location across Tunisia

Drugs / interventions tested

distal radial artery approach
conventional radial artery approach

Conditions studied

Vascular Access Complication — all drugs for Vascular Access Complication →
Coronary Artery Disease — all drugs for Coronary Artery Disease →

Sponsor

General Administration of Military Health, Tunisia — full company profile →

Who can join

18 and older, any sex, with Vascular Access Complication or Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this non-inferiority trial is to determine if the distal radial access (DRA) during percutaneous coronary intervention (PCI) has an acceptable efficacy compared to the reference access through the conventional radial artery (TRA) with a lower rate of radial artery occlusion (RAO) in real life practice.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Evaluation of the Distal Radial Approach in percutaneous coronary interventions. Controlled, randomized non-inferiority trial.
Ben Amara A, Noamen A, Anouar Y, Chenik S, et al · · 2022 · cited 2× · PMID 36005910
Evaluation of the distal radial approach in percutaneous coronary interventions. A controlled, randomized non-inferiority trial.
Noamen A, Ben Amara A, Ben Ayed H, Jabloun TY, et al · · 2023 · cited 1× · PMID 38372550

Verify or expand the search:

Other recruiting trials for Vascular Access Complication

Currently open trials in the same condition.

NCT07372027 — Single-Needle Distal Return for Long-Term Arteriovenous Fistula Care · NA · recruiting
NCT07179536 — Time to Ambulation After ProGlide Closure · NA · recruiting
NCT05490225 — Access Cannulation Trial II · NA · recruiting
NCT06770374 — Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Ca · NA · recruiting
NCT06566495 — Microorganisms on Reusable Tourniquets · active not recruiting

Other General Administration of Military Health, Tunisia trials

Trials by the same sponsor.

NCT06283329 — Residual Vocal Cords Curarization Correlation Between Clinical and Ultrasound Endpoints · completed
NCT05993312 — Quality of Life in Traumatic Brain Injury Patients · unknown
NCT06021912 — e-ITAG Allergen Immunotherapy in the Management of Allergic Asthma · unknown
NCT05516173 — Role of Depression in Blood Pressure Control. Study · unknown
NCT05822180 — Evaluation of the Efficacy and Safety of Nano-S1 · Phase 3 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05311111 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by General Administration of Military Health, Tunisia
Last refreshed: 11 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05311111.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing